Jarrett v. Wright Med. Tech.

CourtU.S. District Court — Southern District of Indiana
Writing for the CourtSARAH EVANS BARKER, United States District Judge
Decision Date22 September 2021
Docket Number1:12-cv-00064-SEB-DML
CitationJarrett v. Wright Med. Tech., 1:12-cv-00064-SEB-DML (S.D. Ind. Sep 22, 2021)
PartiesCOLEMAN JARRETT, et al. Plaintiffs, v. WRIGHT MEDICAL TECHNOLOGY, INC., Defendant.
ORDER

SARAH EVANS BARKER, United States District Judge

This cause is before the Court on the Motion for Summary Judgment [Dkt. 84] filed by Defendant Wright Medical Technology, Inc. ("Wright Medical"). Plaintiffs Coleman and Paula Jarrett commenced this action in 2012 and it was transferred to the United States District Court for the Northern District of Georgia as part of a multidistrict litigation styled "CONSERVE® Hip Implant Product Liability Litigation MDL 2329" ("the MDL"). This case was remanded and transferred to our court to proceed individually on July 6, 2018.

On October 1, 2018, Plaintiffs filed their Second Amended Complaint in this individual action, setting forth claims against Wright Medical under the Indiana Products Liability Act, IND. CODE § 34-20-1-1, et seq. ("the IPLA") relating to Mr. Jarrett's receipt of hip implant components from Wright Medical's CONSERVE® product line during a July 17, 2006 left total hip arthroplasty. Plaintiffs allege that, based on purported defects in the CONSERVE® devices, generally relating to alleged design defects that allegedly caused excessive metal ion release and loosening of the CONSERVE® Cup device Mr. Jarrett was forced to undergo a second "revision" surgery on July 12, 2010 to remove the CONSERVE® devices. In addition to the IPLA claim Plaintiffs also allege a loss consortium claim as well as a request for punitive damages. Wright Medical has moved for summary judgment on each of Plaintiffs' claims.

For the reasons detailed below, we GRANT Defendant's Motion for Summary Judgment as to Plaintiffs' manufacturing defect, failure-to-warn, and fraud theories under the IPLA as well as Plaintiffs' punitive damages request and DENY the motion as to Plaintiffs' IPLA claim based on a design defect theory and the loss of consortium claim.

Factual Background
I. Wright Medical's CONSERVE® Devices

Hip arthroplasty is a surgical procedure that involves replacing the failed natural hip joint with a fabricated replacement, which is intended to improve mobility and relieve pain associated with degenerative hip disease and other bone quality conditions. Exh. A. at 5; Exh. D at 1-3; Exh. E at 1. Wright Medical's CONSERVE® line of products, which belong to a category of hip prostheses referred to as metal-on-metal ("MoM"), is one type of fabricated replacement used in such procedures. The components of a MoM prostheses include a linerless, high carbon, cobalt-chrome cup, and a large diameter high carbon, cobalt-chrome femoral head. See FDA Publication, Effectiveness of Metal-on-Metal Hip Implants, available at https://www.fda.gov/medical-devices/metal-metal-hip-implants/effectiveness-metal-metal-hip-implants (last updated March 15, 2019); see also Exh. F. Wright Medical began moving into the MoM hip prosthesis market in the early 1990s and strove to be the first company to market such products in the United States. Exh. 1 at WMTMDL0068460.

II. Wright Medical's Knowledge of Risks Related to CONSERVE® Devices

In November 1995, two Wright Medical employees, including the Vice President of Development & Technology, attended a four-day conference on MoM technology at which questions were raised regarding whether MoM devices were a good alternative to poly devices and attendees were informed that more needed to be learned and studied regarding the risks associated with metal-metal bearing surfaces. Exh. 2. That same year, Wright Medical was notified by several surgeons and medical product designers of several significant risks regarding MoM devices that required further testing, including concerns regarding metal toxicity, inflammation, bone loss, allergic reaction, local tumor formation, systemic effects, soft tissue necrosis, osteolysis, and blood-born metal ions. Carroll Dep. at 106-111, 134-35. Wright Medical was also aware at that time that the McKee-Farrar device, a MoM design first used in 1960, was removed from the market in the 1970s because of problems with osteolysis, inflammation, cystic responses, cytoxic metal ions, and tissue reactions in implant patients, which conditions necessitated revisions in 50% of the implants. Id. at 113-14.

Wright Medical knew, both when it designed its CONSERVE® devices and throughout the time it was developing, manufacturing, marketing, and selling those devices, of the principles and concerns associated with MoM devices generating wear debris and releasing toxic cobalt and chromium heavy metal ions. Id. at 106-110, 11416, 164-66; Fisher Dep. at 170-71, 173-74, 176, 326-27; Batts Dep. at 101-105; Timmerman Dep. at 76, 85. Wright Medical was also aware prior to Mr. Jarrett's hip replacement surgery that cobalt and chromium ions can cause metallosis, necrosis, inflammation, bone loss, cup loosening, ALVAL, and pseudotumors, and that such ions can have toxic effects, cytotoxicity, indirect sensitization, and carcinogenicity, but was unaware of the long-term consequences to patients of exposure to such ions. Carroll Dep. at 97-99, 113-15, 134-35, 169-70, 238; Exh. 5 and Exh. 9 to Mosely Dep.; Timmerman Dep. at 85. Wright Medical's biggest concern in selling its CONSERVE® devices was the issue of metal ion release; the "number one concern" of surgeons "was the metal ions." Fisher Dep. at 173; Jerome Dep. at 95. At least as early as 2003, Wright Medical understood that, because "metallic particulate debris is approximately an order of magnitude smaller than PE debris, . even low rates of volumetric wear can lead to a large number of particles." Exh. 8.

Prior to marketing and selling the CONSERVE® devices, including the device implanted in Mr. Jarrett in 2006, Wright Medical did not conduct any studies to investigate the risks associated with metal ion release or other "hot-button" issues that led surgeons to reject MoM implants in the 1970s. Moseley Dep. at 80; Exh. 11 at 20-26. Nor did Wright Medical perform any biocompatibility or other testing to determine whether metal-ion release from the CONSERVE® devices was safe. Fisher Dep. at 19093; Svarczkopf Dep. at 157-63; Moseley Dep. at 80.

III. Wright Medical's Marketing of the CONSERVE® Devices

Wright Medical marketed its CONSERVE® devices and components under the tagline: "Tested, Trusted." Exh. 13. The company's marketing materials included the following testimonials from patients and surgeons:

• "Before the surgery, I couldn't run. I couldn't play soccer. Now, there's no pain in the joint at all. Hip replacement gave me my life back." Exh. 15.
• "Because the procedure allows him to be as aggressive as we wanted to be, there -there was no reason for me to tell him to hold back." Exh. 16.
• "Some patients have been able to pursue more vigorous activities, including martial arts, hockey, running marathons, even climbing Mount Kilimanjaro." Exh. 17.
• "Wright Medical, which makes the Conserve Total hip said hip replacement lasts 25 to 30 years." Exh. 18.

In marketing its CONSERVE® devices, Wright Medical determined in 2004 that it needed to "address the metal ion issue in order to convince surgeons . that metal ions are not an issue with [its] system." Exh. 40 to Timmerman Dep.; accord Batts Dep. at 114. In line with this strategy, at ¶ 2002 meeting, Wright Medical instructed its sales representatives, who acted as the company's direct contact with surgeons, that "[t]he effects of metal ion release are known and have been demonstrated to be safe" and that "[t]he effects of polyethylene debris are known, and have been demonstrated to lead to revision surgery." Exh. 29 to Watson Dep.

Wright Medical represented in its marketing materials that MoM hips had a long clinical use but did not provide information regarding the failure rates of either MoM or poly devices. Smith Dep. at 51. Wright Medical's marketing materials also stated that it was widely believed that less than one percent of patients have MoM hypersensitivity reactions and that, in a clinical trial with 1800 patients, none suffered a pseudotumor following surgery, but did not provide information regarding whether that study applied to total hip replacements. Id. at 52-53.

IV. Mr. Jarrett's Original Hip Surgery

In 2006, Mr. Jarrett experienced increasing hip pain exacerbated by a fall and ultimately underwent a left total hip replacement performed by Andrew Parr, M.D. on July 17, 2006 for bone-on-bone degenerative joint disease. Parr Dep. at 7; 47; C. Jarrett Dep. at 65-66. At the time of the surgery, Mr. Jarrett was 47 years of age and had a medical history that included other concurrent conditions including obesity, degenerative lumbar disease and radiating pain, enlarged prostate, and diabetes, among others, although he reported that, before his fall, he was still able to remain relatively active. Parr Dep. at 42, 45-46; C. Jarrett Dep. at 42, 50, 52, 72. Based on Mr. Jarrett's condition, Dr. Parr chose to implant CONSERVE® MoM devices. Parr Dep. at 22, 28.

Prior to the surgery, Mr. Jarrett did not have any specific discussions with Dr. Parr regarding the devices that would be used, beyond a general conversation in which Dr. Parr explained that, based on Mr. Jarrett's relatively young age and activity level, the implanted devices would be MoM. Jarrett Dep. at 79-80. Mr. Jarrett did not conduct any research regarding Wright Medical or the CONSERVE® devices or speak with anyone from Wright Medical prior to his hip replacement surgery and does not recall receiving any brochures or materials from Wright Medical. Id. at 11-12, 92. According to Mr. Jarrett, he did not know that he was being implanted with Wright Medical products at the time...

Get this document and AI-powered insights with a free trial of vLex and Vincent AI

Get Started for Free

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex